Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.026 AUD 13.04% Market Closed
Market Cap: 53.3m AUD
Have any thoughts about
Bioxyne Ltd?
Write Note
BXN
/
Income Statement
/
Cost of Revenue

Bioxyne Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioxyne Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bioxyne Ltd
ASX:BXN
Cost of Revenue
-AU$5.9m
CAGR 3-Years
-79%
CAGR 5-Years
-43%
CAGR 10-Years
-17%
McPherson's Ltd
ASX:MCP
Cost of Revenue
-AU$68.1m
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
10%
Star Combo Pharma Ltd
ASX:S66
Cost of Revenue
-AU$20.3m
CAGR 3-Years
5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Elixinol Wellness Ltd
ASX:EXL
Cost of Revenue
-AU$4.8m
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
N/A
B
Biome Australia Ltd
ASX:BIO
Cost of Revenue
-AU$5.1m
CAGR 3-Years
-65%
CAGR 5-Years
-97%
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Cost of Revenue
-$4.6m
CAGR 3-Years
-24%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

Bioxyne Ltd
Glance View

Market Cap
53.2m AUD
Industry
Consumer products

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.

BXN Intrinsic Value
0.008 AUD
Overvaluation 70%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Bioxyne Ltd's Cost of Revenue?
Cost of Revenue
-5.9m AUD

Based on the financial report for Jun 30, 2024, Bioxyne Ltd's Cost of Revenue amounts to -5.9m AUD.

What is Bioxyne Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-17%

Over the last year, the Cost of Revenue growth was -59%. The average annual Cost of Revenue growth rates for Bioxyne Ltd have been -79% over the past three years , -43% over the past five years , and -17% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.